SPECTRUM PHARMACEUTICALS INC (SPPI)

US84763A1088 - Common Stock

1.03  0 (0%)

After market: 1.04 +0.01 (+0.97%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
10.114M74.844M
640.00%
EBITDA
YoY % growth
-149.74M
-5.42%		-142.517M
4.82%		-72.449M
49.16%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-150M
-5.34%		-142.803M
4.80%		-72.697M
49.09%		-38.283M
47.34%
Operating Margin
N/AN/A-718.78%-51.15%
EPS
YoY % growth
-1.30
-20.37%		-1.04
20.00%		-0.42
59.62%		-0.05
88.67%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.03
80.00%
Revenue
Q2Q % growth		16.853M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-6.106M
75.95%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 -0.02
75.00%		-0.070.0569.36%
Q4 2022
Q2Q % growth		 -0.05
80.77%		-0.110.0654.61%
Q3 2022
Q2Q % growth		 -0.12
42.86%		-0.150.0320.24%
Q2 2022
Q2Q % growth		 -0.17
46.88%		-0.16-0.01-5.49%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 15.615M
∞%		11.188M4.427M39.57%
Q4 2022
Q2Q % growth		 10.114M
∞%		9.098M1.016M11.17%
Q3 2022
Q2Q % growth		 %
Q2 2022
Q2Q % growth		 %
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 44.45% 78.12% 78.12%
Revenue0% 40.01% 47.89% 47.89%